Literature DB >> 10449197

Diphenylamine as an important structure of nonsteroidal anti-inflammatory drugs to uncouple mitochondrial oxidative phosphorylation.

Y Masubuchi1, S Yamada, T Horie.   

Abstract

A marked difference has been observed in the inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on oxidative phosphorylation of rat liver mitochondria. It should be noted that some of the potent inhibitors, N-phenylanthranilic acids and diclofenac, have a similar "skeleton" structure, diphenylamine. Diphenylamine itself was found to inhibit oxidative phosphorylation significantly, although its inhibition potency was weaker than that of NSAIDs with a diphenylamine structure. In addition to decreases in the respiration control index (ratio of state 3 to state 4 respiration), these compounds released oligomycin-inhibited state 3 respiration. These results demonstrated that diphenylamine, as well as N-phenylanthranilic acids and diclofenac, was an uncoupler of oxidative phosphorylation of rat liver mitochondria. Thus, diphenylamine was suggested to play an important role in the uncoupling effects of NSAIDs with a diphenylamine skeleton.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449197     DOI: 10.1016/s0006-2952(99)00163-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Measuring interference of drug-like molecules with the respiratory chain: toward the early identification of mitochondrial uncouplers in lead finding.

Authors:  Ursula Stock; Hans Matter; Kerstin Diekert; Wolfgang Dörner; Stefan Dröse; Thomas Licher
Journal:  Assay Drug Dev Technol       Date:  2013-08-30       Impact factor: 1.738

2.  Mitochondrial dysfunction induced by sertraline, an antidepressant agent.

Authors:  Yan Li; Letha Couch; Masahiro Higuchi; Jia-Long Fang; Lei Guo
Journal:  Toxicol Sci       Date:  2012-03-02       Impact factor: 4.849

3.  CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Authors:  Mary Alexandra Schleiff; Samantha Crosby; Madison Blue; Benjamin Mark Schleiff; Gunnar Boysen; Grover Paul Miller
Journal:  Biochem Pharmacol       Date:  2021-11-05       Impact factor: 5.858

4.  Chemical Exchange Saturation Transfer (CEST) Agents: Quantum Chemistry and MRI.

Authors:  Jikun Li; Xinxin Feng; Wei Zhu; Nikita Oskolkov; Tianhui Zhou; Boo Kyung Kim; Noman Baig; Michael T McMahon; Eric Oldfield
Journal:  Chemistry       Date:  2015-11-30       Impact factor: 5.236

5.  Impacts of diphenylamine NSAID halogenation on bioactivation risks.

Authors:  Mary Alexandra Schleiff; Sasin Payakachat; Benjamin Mark Schleiff; S Joshua Swamidass; Gunnar Boysen; Grover Paul Miller
Journal:  Toxicology       Date:  2021-06-06       Impact factor: 4.571

6.  Metabolic and Evolutionary Insights in the Transformation of Diphenylamine by a Pseudomonas putida Strain Unravelled by Genomic, Proteomic, and Transcription Analysis.

Authors:  Evangelia S Papadopoulou; Chiara Perruchon; Sotirios Vasileiadis; Constantina Rousidou; Georgia Tanou; Martina Samiotaki; Athanassios Molassiotis; Dimitrios G Karpouzas
Journal:  Front Microbiol       Date:  2018-04-06       Impact factor: 5.640

7.  Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics.

Authors:  Mary Alexandra Schleiff; Noah R Flynn; Sasin Payakachat; Benjamin Mark Schleiff; Anna O Pinson; Dennis W Province; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Drug Metab Dispos       Date:  2020-11-25       Impact factor: 3.922

8.  A Molecular Biophysical Approach to Diclofenac Topical Gastrointestinal Damage.

Authors:  Eduarda Fernandes; Telma B Soares; Hugo Gonçalves; Sigrid Bernstorff; Maria Elisabete C D Real Oliveira; Carla M Lopes; Marlene Lúcio
Journal:  Int J Mol Sci       Date:  2018-10-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.